Mirum Pharmaceuticals, Inc.
MIRM
$44.39
-$0.88-1.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 277.67M | 280.32M | 284.45M | 278.37M | 302.84M |
| Total Receivables | 95.85M | 78.29M | 68.53M | 60.43M | 55.00M |
| Inventory | 22.42M | 22.40M | 21.59M | 20.44M | 21.61M |
| Prepaid Expenses | 14.87M | 11.78M | 12.06M | 8.59M | 10.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 410.82M | 392.79M | 386.63M | 367.83M | 389.47M |
|
|
|||||
| Total Current Assets | 410.82M | 392.79M | 386.63M | 367.83M | 389.47M |
| Net Property, Plant & Equipment | 8.77M | 9.81M | 10.35M | 9.86M | 1.18M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 243.85M | 249.82M | 255.79M | 261.77M | 257.44M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.90M | 5.81M | 5.81M | 4.22M | 3.87M |
| Total Assets | 690.25M | 670.75M | 667.89M | 660.75M | 651.96M |
|
|
|||||
| Total Accounts Payable | 11.64M | 14.62M | 9.55M | 9.84M | 15.98M |
| Total Accrued Expenses | 64.07M | 72.86M | 64.11M | 54.15M | 49.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.64M | 1.71M | 1.51M | 1.07M | 358.00K |
| Total Finance Division Other Current Liabilities | 50.22M | 37.36M | 40.59M | 47.25M | 40.01M |
| Total Other Current Liabilities | 50.22M | 37.36M | 40.59M | 47.25M | 40.01M |
| Total Current Liabilities | 127.58M | 126.55M | 115.75M | 112.31M | 105.91M |
|
|
|||||
| Total Current Liabilities | 127.58M | 126.55M | 115.75M | 112.31M | 105.91M |
| Long-Term Debt | 308.51M | 308.08M | 307.67M | 307.24M | 306.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 7.00M | 7.97M | 8.48M | 8.24M | 328.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.90M | 2.51M | 3.97M | 3.97M | 4.29M |
| Total Liabilities | 456.99M | 445.11M | 435.87M | 431.77M | 417.36M |
|
|
|||||
| Common Stock & APIC | 892.37M | 870.19M | 851.50M | 835.62M | 816.13M |
| Retained Earnings | -658.86M | -644.18M | -620.39M | -606.16M | -581.52M |
| Treasury Stock & Other | -258.00K | -373.00K | 920.00K | -477.00K | -13.00K |
| Total Common Equity | 233.26M | 225.64M | 232.02M | 228.99M | 234.60M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 233.26M | 225.64M | 232.02M | 228.99M | 234.60M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 233.26M | 225.64M | 232.02M | 228.99M | 234.60M |
|
|
|||||